Zavzpret, a branded formulation of the generic drug zavegepant, is the "first and only" calcitonin gene-related peptide receptor antagonist nasal spray for treating migraines with or without an aura, or sensory disturbances such as flashes of light that can accompany a migraine.
New programs like Hospital-at-Home and Acute-Care-at-Home are giving health systems an opportunity to reduce inpatient traffic and give patients the care they need in their own homes.
...
Recent CMS and CDC rulings offer hope that health systems will show more love for innovative treatments like digital therapeutics and virtual platforms.
...
The Rhode Island School of Design's Center for Complexity has developed a new tool that helps non-English patients accurately describe their pain for emergency care providers.
...
